Tandem Diabetes Care (TNDM) Current Deferred Revenue (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Current Deferred Revenue came in at $9.0 million in Q1 2026, down 18.43% YoY from $11.0 million in Q1 2025, and down 6.01% on a QoQ basis from $9.5 million in Q4 2025.
Tandem Diabetes Care (TNDM) Current Deferred Revenue (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Current Deferred Revenue data on file, last reported at $9.0 million in Q1 2026.
- Quarterly Current Deferred Revenue fell 18.43% year-over-year to $9.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.0 million (down 18.43% YoY) and the FY2025 annual result came in at $9.5 million, down 19.47% from the prior year.
- Current Deferred Revenue retreated to $9.0 million in Q1 2026, from $9.5 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $44.0 million in Q4 2023 to a low of $1.1 million in Q1 2024.
- A 5-year average of $16.5 million and a median of $11.7 million in 2022 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2024 — Current Deferred Revenue sank 95.3% — and 2025, when it surged 897.91%.
- Tracing TNDM's Current Deferred Revenue over 5 years: stood at $18.8 million in 2022, then jumped by 133.55% to $44.0 million in 2023, then plunged by 73.11% to $11.8 million in 2024, then retreated by 19.47% to $9.5 million in 2025, then slipped by 6.01% to $9.0 million in 2026.
- The last three Current Deferred Revenue figures came in at $9.0 million (Q1 2026), $9.5 million (Q4 2025), and $9.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.57 Bn | 1.11 Bn | 144.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.43 Mn |
| Mar 31, 2026 | 8.95 Mn |
| Dec 31, 2025 | 9.53 Mn |
| Sep 30, 2025 | 9.84 Mn |
| Jun 30, 2025 | 10.52 Mn |
| Mar 31, 2025 | 10.98 Mn |
| Dec 31, 2024 | 11.83 Mn |
| Sep 30, 2024 | 42.57 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 43.99 Mn |
| Sep 30, 2023 | 31.61 Mn |
| Jun 30, 2023 | 23.40 Mn |
| Mar 31, 2023 | 20.76 Mn |
| Dec 31, 2022 | 18.84 Mn |
| Sep 30, 2022 | 12.97 Mn |
| Jun 30, 2022 | 11.71 Mn |
| Mar 31, 2022 | 10.88 Mn |
| Dec 31, 2021 | 10.18 Mn |
| Sep 30, 2021 | 9.02 Mn |